Dec 31, 2025 • MarketBeat
NEUTRAL
article title here
brief 2-3 sentence summary of the article
Dec 30, 2025 • MarketBeat
BULLISH
Cardinal Health, Inc. (NYSE:CAH) Short Interest Down 22.2% in December
Cardinal Health, Inc. (NYSE:CAH) experienced a significant 22.2% decrease in short interest during December, with shorted shares totaling 4,904,967 as of December 15th, representing a short-interest ratio of 1.9 days. The company recently reported strong Q3 earnings, beating estimates with $2.55 EPS and $64.01 billion in revenue, and announced a quarterly dividend of $0.5107. Analysts currently hold a "Moderate Buy" rating for CAH with a consensus target price of $209.00.
Dec 30, 2025 • MarketBeat
NEUTRAL
Cardinal Health, Inc. $CAH Shares Sold by Simplify Asset Management Inc.
Simplify Asset Management Inc. reduced its holdings in Cardinal Health, Inc. (NYSE:CAH) by 47.4% in the third quarter, selling 11,006 shares and retaining 12,223 shares valued at approximately $1.912 million. Despite this, other institutional investors have recently increased their stakes, and analysts have issued a "Moderate Buy" consensus rating with an average price target of $209.00. Cardinal Health recently reported strong quarterly earnings, beating estimates and providing a positive FY2026 EPS guidance, alongside announcing a quarterly dividend.
Dec 30, 2025 • openPR.com
BULLISH
IV Bags Market to See Massive Growth with Baxter, B. Braun, Fresenius Kabi, and Terumo
Coherent Market Insights has released a research report on the IV Bags Market, forecasting substantial growth from 2025 to 2032. The report provides a deep dive into market trends, drivers, challenges, and the competitive landscape, featuring key players like Baxter International, B. Braun Melsungen AG, and Fresenius Kabi AG. It offers insights for strategic decision-making through comprehensive segmentation, analytical tools, and a geographical landscape overview.
Dec 29, 2025 • Yahoo Finance
SOMEWHAT-BULLISH
U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More
The U.S. Embolic Protection Device Market is projected to grow from US$360 million in 2024 to US$650 million by 2033, with a CAGR of 6.96%. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, an aging population, and technological advancements in device design. Key challenges include the high cost of devices and complexities in reimbursement, as well as the need for highly skilled operators to properly use these devices.
Dec 29, 2025 • openPR.com
SOMEWHAT-BULLISH
Patient Liaison Assistance Market Is Going to Boom |McKesson Corporation • 2. Cardinal Health
Worldwide Market Reports has released a new study predicting substantial growth for the "Patient Liaison Assistance Market." The report offers a comprehensive analysis of market dynamics, competitive landscape including key players like McKesson and Cardinal Health, and segmental highlights by types and applications. It also provides regional insights, research methodology, and actionable intelligence to support business growth and investment decisions.